Download video

Young Potential Trainee programme I Selma Droschke and Josef Basilious

29 views

Scania Group

1 year ago

Young Potential Trainee programme I Selma Droschke and Josef Basilious

Young Potential Trainee programme I Selma Droschke and Josef Basilious

Potency and efficacy of PIP4K2 inhibitors in ALL: looking forward to first-in-human trials
0:52
Potency and efficacy of PIP4K2 inhibitors in ALL: looking forward to first-in-human trials
by VJHemOnc – Video Journal of Hematology \& HemOnc
2024PawseyInternANg
4:27
2024PawseyInternANg
by Pawsey Supercomputing Research Centre
PEMMELA cohort 2: second line pembrolizumab and lenvatinib in PM
0:55
PEMMELA cohort 2: second line pembrolizumab and lenvatinib in PM
by VJOncology
PINN6222 POE P2
7:14
PINN6222 POE P2
by EHM Collective
Updated results of AUGMENT-101: revumenib in R\/R KMT2Ar acute leukemia
0:48
Updated results of AUGMENT-101: revumenib in R\/R KMT2Ar acute leukemia
by VJHemOnc – Video Journal of Hematology \& HemOnc
4 examples of use 2m2s
2:03
4 examples of use 2m2s
by rgccusa
Highlights of Webinar: Specialist Adolescent and Young Adults Units Minimum Standard
5:46
Highlights of Webinar: Specialist Adolescent and Young Adults Units Minimum Standard
by European Youth Cancer Network
PPR22: Thomas Rowbal
4:12
PPR22: Thomas Rowbal
by Applebaum College of Pharmacy \& Health Sciences
Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
1:00:50
Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
by Research To Practice
Menin inhibition in AML: clinical guidance and future directions
7:31
Menin inhibition in AML: clinical guidance and future directions
by VJHemOnc – Video Journal of Hematology \& HemOnc
My Cancer Treatment Story: \\
26:11
My Cancer Treatment Story: \\"I Researched Everything\\" | Nicky's Lymphoma Story | The Patient Story
by The Patient Story
Prostaglandin E2's Role in Senescence and Neoplastic Escape in Human Keratinocytes | Aging-US
2:24
Prostaglandin E2's Role in Senescence and Neoplastic Escape in Human Keratinocytes | Aging-US
by Aging-US
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
1:10
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
by VJOncology
Identifying potential targets for treating SRSF2-mutated AML
3:21
Identifying potential targets for treating SRSF2-mutated AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
AS 2016 2 P06 R02 manual x264
0:25
AS 2016 2 P06 R02 manual x264
by Robinson Research Institute
WORLD'S TOP 2% 17 scientists from @universityoftheaegean6066
1:26
WORLD'S TOP 2% 17 scientists from @universityoftheaegean6066
by UAegean Research and Innovation
I2DL - Lecture 08: Augmentation and Regularization
1:35:28
I2DL - Lecture 08: Augmentation and Regularization
by cvprtum
01Jul21 | P2Cs - The Mole
6:01
01Jul21 | P2Cs - The Mole
by Polder2C's Living Lab Hedwige-Prosperpolder
Improving the assessment of response in relapsed MM
1:47
Improving the assessment of response in relapsed MM
by VJHemOnc – Video Journal of Hematology \& HemOnc
RPYSOC 24 - 22 Nov - Day two morning 2
1:02:56
RPYSOC 24 - 22 Nov - Day two morning 2
by NHS-R Community
Interim analysis of the ELM-2 study: odronextamab in patients with R\/R follicular lymphoma
2:43
Interim analysis of the ELM-2 study: odronextamab in patients with R\/R follicular lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
GZ17-6.02 Interacts with Proteasome Inhibitors to Kill Multiple Myeloma Cells | Oncotarget
2:20
GZ17-6.02 Interacts with Proteasome Inhibitors to Kill Multiple Myeloma Cells | Oncotarget
by Oncotarget